Pfizer Inc. - Pfizer Provides Update on Phase 3 PALLAS Trial of IBRANCE® (palbociclib) Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer

$PFE 

Bugger - that’s why you want a broad portfolio and pipeline! https://t.co/GaNdWYP3fk